These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19191661)

  • 1. HIV drug resistance tests: an update on methods for calculating phenotypic fold change from a viral genotype.
    Bellosillo NA; Bacheler L; Villacian J
    Clin Infect Dis; 2009 Mar; 48(5):687; author reply 687. PubMed ID: 19191661
    [No Abstract]   [Full Text] [Related]  

  • 2. Update of the drug resistance mutations in HIV-1: December 2009.
    Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2009 Dec; 17(5):138-45. PubMed ID: 20068260
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessments of HIV drug resistance mutations in resource-limited settings.
    Jordan MR
    Clin Infect Dis; 2011 Apr; 52(8):1058-60. PubMed ID: 21460325
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting the concept of a genetic barrier to resistance.
    Rusconi S
    J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinically validated genotype analysis.
    Flandre P
    Antivir Ther; 2004 Dec; 9(6):1037-8; author reply 1038-9. PubMed ID: 15651764
    [No Abstract]   [Full Text] [Related]  

  • 6. Update of the drug resistance mutations in HIV-1: 2007.
    Johnson VA; Brun-Vézinet F; Clotet B; Günthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2007; 15(4):119-25. PubMed ID: 17720996
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-resistance patterns in women discovered. Resistance testing necessary, expert says.
    AIDS Alert; 2005 Jan; 20(1):7-8. PubMed ID: 15717355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated guide to genotype interpretation.
    MacArthur RD
    AIDS Read; 2004 May; 14(5):256-8, 261-4, 266. PubMed ID: 15199855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 10. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
    Zolopa AR
    J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the drug resistance situation among recently infected HIV-1 patients in Dehong].
    Wang MJ; Duan S; Xiang LF; Yang YC; Tu YQ; Wang JB; Yao J; Qi J; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):905-8. PubMed ID: 19173856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
    Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
    J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
    Posit Aware; 2006; Spec No():17-22. PubMed ID: 16596730
    [No Abstract]   [Full Text] [Related]  

  • 15. Update of the Drug Resistance Mutations in HIV-1.
    Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in understanding the evolution of HIV.
    Crandall KA; Vasco DA; Posada D; Imamichi H
    AIDS; 1999; 13 Suppl A():S39-47. PubMed ID: 10885761
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 19. Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
    Malet I; Delelis O; Soulie C; Wirden M; Tchertanov L; Mottaz P; Peytavin G; Katlama C; Mouscadet JF; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2009 Apr; 63(4):795-804. PubMed ID: 19221102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance development. Are drug resistant HIV-1 minorities relevant for therapeutic success?].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():15. PubMed ID: 19024909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.